SR.NO. | PRODUCT NAME | THERAPEUTICAL CLASS |
1 | Abiraterone tablets 250 mg | Androgen biosynthesis inhibitors |
2 | Abiraterone tablets 500 mg | Androgen biosynthesis inhibitors |
3 | Afatinib tablets 20 mg | Kinase inhibitor |
4 | Afatinib tablets 40 mg | Kinase inhibitor |
5 | Anastrazole tablets 1 mg | Nonstreroidal Aromatase inhibitor |
6 | Apalutamide tablets 60 mg | Androgen recepto inhibitors |
7 | Axitinib tablets 1 mg | Kinase inhibitors |
8 | Axitinib tablets 5 mg | Kinase inhibitors |
9 | Azacitadine tablets 200 mg | Demethylation agent |
10 | Azacitadine tablets 200 mg | Demethylation agent |
11 | Bicalutamide tablets 50 mg | nonsteroidal antiandrogen |
12 | Capecitabine tablets 500 mg | Fluoropyridine |
13 | Carbozantinib tablets 20 mg | Kinase inhibitors |
14 | Carbozantinib tablets 40 mg | Kinase inhibitors |
15 | Carbozantinib tablets 60 mg | Kinase inhibitors |
16 | Cyclophosphamide tablets 50 mg | Alkalyting agent |
17 | Dasatanib tablets 100 mg | Kinase inhibitors |
18 | Dasatanib tablets 20 mg | Kinase inhibitors |
19 | Dasatanib tablets 50 mg | Kinase inhibitors |
20 | Dasatanib tablets 70 mg | Kinase inhibitors |
21 | Eltrombopag tablets 25 mg | Thrombopoetin Receptor Agonist |
22 | Eltrombopag tablets 50 mg | Thrombopoetin Receptor Agonist |
23 | Enzalutamide tablets 160 mg | Androgen recepto inhibitors |
24 | Erlotinib tablets 100 mg | Kinase inhibitors |
25 | Erlotinib tablets 150 mg | Kinase inhibitors |
26 | Etoposide tablets 50 mg | Topoisomerase II inhibitors |
27 | Everolimus tablets 10 mg | Kinase inhibitors |
28 | Everolimus tablets 5 mg | Kinase inhibitors |
29 | Gefitinib tablets 250 mg | Kinase inhibitors |
30 | Imatinib tablets 100 mg | Kinase inhibitors |
31 | Imatinib tablets 400 mg | Kinase inhibitors |
32 | lapatinib tablets 250 mg | Kinase inhibitors |
33 | Lenvatinib tablets 10 mg | Lenvatinib |
34 | Lenvatinib tablets 4 mg | Lenvatinib |
35 | Letrozole tablets 2.5 mg | Nonstreroidal Aromatase inhibitor |
36 | Magestrol acetate tablets 160 mg | Progestic class |
37 | Magestrol acetate tablets 40 mg | Progestic class |
38 | Mercaptopurine tablets 50 mg | Purine antagonist |
39 | Methotrexate tablets 2.5 mg | Antimetabolites |
40 | Methotrexate tablets 5 mg | Antimetabolites |
41 | Methotrexate tablets 7.5 mg | Antimetabolites |
42 | Pazopanib tablets 200 mg | Kinase inhibitors |
43 | Pazopanib tablets 400 mg | Kinase inhibitors |
44 | Rucaparib tablets 200 mg | Poly (Adp-ribose) polymearse (PAR) inhibitors |
45 | Rucaparib tablets 300 mg | Poly (Adp-ribose) polymearse (PAR) inhibitors |
46 | Sorafenib tablets 200 mg | Kinase inhibitors |
47 | Sunitinib Tablets 12.5 mg | Kinase inhibitors |
48 | Sunitinib Tablets 25 mg | Kinase inhibitors |
49 | Sunitinib Tablets 50 mg | Kinase inhibitors |
50 | Tamoxifen tablets 10 mg | Antiestrogens |
51 | Tamoxifen tablets 20 mg | Antiestrogens |
52 | Thalidomide tablets 100 mg | Immunimodulatory |
53 | Thalidomide tablets 250 mg | Immunimodulatory |
54 | Thalidomide tablets 50 mg | Immunimodulatory |
SR.NO. | PRODUCT NAME | THERAPEUTICAL CLASS |
1 | Aprepitant capsules 125 mg | Neurokinin -1-antagonist |
2 | Aprepitant capsules 80 mg | Neurokinin -1-antagonist |
3 | Enzalutamide capsules 40 mg | Androgen recepro inhibors |
4 | Hydroxy urea capsules 500 mg | Antimetabolites |
5 | Lenalidomide capsules 10 mg | Immunimodulatory |
6 | Lenalidomide capsules 25 mg | Immunimodulatory |
7 | Lenalidomide capsules 5 mg | Immunimodulatory |
8 | Procarbazine capsules 50 mg | Alkylizing agent |
9 | Tacrolimus capsules 0.5 mg | Calcineurin inhibitor |
10 | Tacrolimus capsules 1 mg | Calcineurin inhibitor |
11 | Tacrolimus capsules 2 mg | Calcineurin inhibitor |
12 | Tacrolimus capsules 5 mg | Calcineurin inhibitor |
13 | Temozolamide capsules 100 mg | Alkylizing agent |
14 | Temozolamide capsules 20 mg | Alkylizing agent |
15 | Temozolamide capsules 250 mg | Alkylizing agent |
SR.NO. | PRODUCT NAME | THERAPEUTICAL CLASS |
1 | Azacitadine for injection 100 mg | Demethylation agent |
2 | Bendamustine HCL for injection 100 mg | Antineoplastic |
3 | Bleomycin 15 IU units | Cytotoxic Chemotherapy |
4 | Bortezomib injection 2 mg | Antineoplastic |
5 | Bortezomib injection 3.5 mg | Antineoplastic |
6 | Carfilzomin injection 60 mg | Proteasome inhibitors |
7 | Dacarbazine injection 100 mg | Purine Analogues |
9 | Dacarbazine injection 200 mg | Purine Analogues |
10 | Dacarbazine injection 500 mg | Purine Analogues |
11 | Dactanomycin injection 0.5 mg | Antitumor antibiotics |
12 | Daunorubicin injection 20 mg | Anthracyclines |
13 | Doxorubicin injection 10 mg | Anthracyclines |
14 | Doxorubicin injection 50 mg | Anthracyclines |
15 | Epirubicin injection 10 mg | Anthracyclines |
16 | Epirubicin injection 50 mg | Anthracyclines |
17 | Fludarabine phosphate injection 50 mg | Purine analogs |
18 | Fosaprepitant injection 150 mg | Antiemetics |
19 | Gemcitabine injection 1000 mg | Antimetabolites |
20 | Gemcitabine injection 1400 mg | Antimetabolites |
21 | Gemcitabine injection 200 mg | Antimetabolites |
22 | L-asparagenase injection 10000 IU | Antineoplastic |
23 | L-asparagenase injection 5000 IU | Antineoplastic |
24 | Mitomycin injection 10 mg | Antineoplastic |
25 | Oxaliplatin injection 100 mg | paltinum base chemotherapeutic |
26 | Oxaliplatin injection 50 mg | paltinum base chemotherapeutic |
27 | Paclitacxel Albumin bound 100 mg | Antimicrotubule agents |
28 | Zoldrenic acid 4 mg | Antiresorptive |
SR.NO. | PRODUCT NAME | THERAPEUTICAL CLASS |
1 | Carbazitaxel injection 60 m+B102:B128g | Microtubule agents |
2 | Carboplatin injection 150 mg | Platinum caoyning compound |
3 | Carboplatin injection 450 mg | Platinum caoyning compound |
4 | Cisplatin injection 100 mg | Alklyzing agent |
5 | Cisplatin injection 50 mg | Alklyzing agent |
6 | Cytarabine injection 100 mg | Antimetabolite & Antineoplastic agent |
7 | Cytarabine injection 1000 mg | Antimetabolite & Antineoplastic agent |
8 | Cytarabine injection 500 mg | Antimetabolite & Antineoplastic agent |
9 | Docetaxel injection (Ready to use) Romm temperature | Taxanes |
10 | Docetaxel injection with solvent (2-8 Degree) | Taxanes |
11 | Doxorubicin injection 50 mg | Anthracyclines |
12 | PEG-Asparagenase 3750 IU | Antineoplastic agent |
13 | Epirubicin injection 10 mg | Anthracyclines |
14 | Epirubicin injection 50 mg | Anthracyclines |
15 | Etoposide injection 100 mg | Topoisomer inhibitords |
16 | Fluorourocil injection 1000 mg | Antimetabolite |
17 | Fluorourocil injection 250 mg | Antimetabolite |
18 | Fluorourocil injection 500 mg | Antimetabolite |
19 | Gemcitabine injection 1000 mg | Antimetabolites |
20 | Gemcitabine injection 1400 mg | Antimetabolites |
21 | Gemcitabine injection 200 mg | Antimetabolites |
22 | Gemcitabine injection 2000 mg | Antimetabolites |
23 | Irinotecan injection 40 mg | DNA topoisomerase I Inhibitors |
24 | Leucovorin calcium injection 100 mg | Folic acid analogs |
25 | Leucovorin calcium injection 300 mg | Folic acid analogs |
26 | Leucovorin calcium injection 50 mg | Folic acid analogs |
27 | Methotrexate injection 50 mg | Antimetabolites |
28 | Methotrexate injection 500 mg | Antimetabolites |
29 | Oxaliplatin injection 100 mg | Platinum base chemotherapeutic |
30 | Oxaliplatin injection 50 mg | Platinum base chemotherapeutic |
31 | Paclitaxel injection 100 mg | Antimicrotubule agents |
32 | Paclitaxel injection 260 mg | Antimicrotubule agents |
33 | Paclitaxel injection 30 mg | Antimicrotubule agents |
34 | Paclitaxel injection 300 mg | Antimicrotubule agents |
35 | Vinblastin injection 10 mg | Vinca alkaloids |
36 | Vincristine injection 1 mg | Vinca alkaloids |
37 | Vinorelbine injection 50 mg | Vinca alkaloids |
ONCOLOGY TABS CAPS INJECTIONS | ||
TABLETS | ||
SR.NO. | PRODUCT NAME | THERAPEUTICAL CLASS |
1 | Abiraterone tablets 250 mg | Androgen biosynthesis inhibitors |
2 | Abiraterone tablets 500 mg | Androgen biosynthesis inhibitors |
3 | Afatinib tablets 20 mg | Kinase inhibitor |
4 | Afatinib tablets 40 mg | Kinase inhibitor |
5 | Anastrazole tablets 1 mg | Nonstreroidal Aromatase inhibitor |
6 | Apalutamide tablets 60 mg | Androgen recepto inhibitors |
7 | Axitinib tablets 1 mg | Kinase inhibitors |
8 | Axitinib tablets 5 mg | Kinase inhibitors |
9 | Azacitadine tablets 200 mg | Demethylation agent |
10 | Azacitadine tablets 200 mg | Demethylation agent |
11 | Bicalutamide tablets 50 mg | nonsteroidal antiandrogen |
12 | Capecitabine tablets 500 mg | Fluoropyridine |
13 | Carbozantinib tablets 20 mg | Kinase inhibitors |
14 | Carbozantinib tablets 40 mg | Kinase inhibitors |
15 | Carbozantinib tablets 60 mg | Kinase inhibitors |
16 | Cyclophosphamide tablets 50 mg | Alkalyting agent |
17 | Dasatanib tablets 100 mg | Kinase inhibitors |
18 | Dasatanib tablets 20 mg | Kinase inhibitors |
19 | Dasatanib tablets 50 mg | Kinase inhibitors |
20 | Dasatanib tablets 70 mg | Kinase inhibitors |
21 | Eltrombopag tablets 25 mg | Thrombopoetin Receptor Agonist |
22 | Eltrombopag tablets 50 mg | Thrombopoetin Receptor Agonist |
23 | Enzalutamide tablets 160 mg | Androgen recepto inhibitors |
24 | Erlotinib tablets 100 mg | Kinase inhibitors |
25 | Erlotinib tablets 150 mg | Kinase inhibitors |
26 | Etoposide tablets 50 mg | Topoisomerase II inhibitors |
27 | Everolimus tablets 10 mg | Kinase inhibitors |
28 | Everolimus tablets 5 mg | Kinase inhibitors |
29 | Gefitinib tablets 250 mg | Kinase inhibitors |
30 | Imatinib tablets 100 mg | Kinase inhibitors |
31 | Imatinib tablets 400 mg | Kinase inhibitors |
32 | lapatinib tablets 250 mg | Kinase inhibitors |
33 | Lenvatinib tablets 10 mg | Lenvatinib |
34 | Lenvatinib tablets 4 mg | Lenvatinib |
35 | Letrozole tablets 2.5 mg | Nonstreroidal Aromatase inhibitor |
36 | Magestrol acetate tablets 160 mg | Progestic class |
37 | Magestrol acetate tablets 40 mg | Progestic class |
38 | Mercaptopurine tablets 50 mg | Purine antagonist |
39 | Methotrexate tablets 2.5 mg | Antimetabolites |
40 | Methotrexate tablets 5 mg | Antimetabolites |
41 | Methotrexate tablets 7.5 mg | Antimetabolites |
42 | Pazopanib tablets 200 mg | Kinase inhibitors |
43 | Pazopanib tablets 400 mg | Kinase inhibitors |
44 | Rucaparib tablets 200 mg | Poly (Adp-ribose) polymearse (PAR) inhibitors |
45 | Rucaparib tablets 300 mg | Poly (Adp-ribose) polymearse (PAR) inhibitors |
46 | Sorafenib tablets 200 mg | Kinase inhibitors |
47 | Sunitinib Tablets 12.5 mg | Kinase inhibitors |
48 | Sunitinib Tablets 25 mg | Kinase inhibitors |
49 | Sunitinib Tablets 50 mg | Kinase inhibitors |
50 | Tamoxifen tablets 10 mg | Antiestrogens |
51 | Tamoxifen tablets 20 mg | Antiestrogens |
52 | Thalidomide tablets 100 mg | Immunimodulatory |
53 | Thalidomide tablets 250 mg | Immunimodulatory |
54 | Thalidomide tablets 50 mg | Immunimodulatory |
CAPSULES | ||
SR.NO. | PRODUCT NAME | THERAPEUTICAL CLASS |
1 | Aprepitant capsules 125 mg | Neurokinin -1-antagonist |
2 | Aprepitant capsules 80 mg | Neurokinin -1-antagonist |
3 | Enzalutamide capsules 40 mg | Androgen recepro inhibors |
4 | Hydroxy urea capsules 500 mg | Antimetabolites |
5 | Lenalidomide capsules 10 mg | Immunimodulatory |
6 | Lenalidomide capsules 25 mg | Immunimodulatory |
7 | Lenalidomide capsules 5 mg | Immunimodulatory |
8 | Procarbazine capsules 50 mg | Alkylizing agent |
9 | Tacrolimus capsules 0.5 mg | Calcineurin inhibitor |
10 | Tacrolimus capsules 1 mg | Calcineurin inhibitor |
11 | Tacrolimus capsules 2 mg | Calcineurin inhibitor |
12 | Tacrolimus capsules 5 mg | Calcineurin inhibitor |
13 | Temozolamide capsules 100 mg | Alkylizing agent |
14 | Temozolamide capsules 20 mg | Alkylizing agent |
15 | Temozolamide capsules 250 mg | Alkylizing agent |
LYOPHILIZED PRODUCT | ||
SR.NO. | PRODUCT NAME | THERAPEUTICAL CLASS |
1 | Azacitadine for injection 100 mg | Demethylation agent |
2 | Bendamustine HCL for injection 100 mg | Antineoplastic |
3 | Bleomycin 15 IU units | Cytotoxic Chemotherapy |
4 | Bortezomib injection 2 mg | Antineoplastic |
5 | Bortezomib injection 3.5 mg | Antineoplastic |
6 | Carfilzomin injection 60 mg | Proteasome inhibitors |
7 | Dacarbazine injection 100 mg | Purine Analogues |
9 | Dacarbazine injection 200 mg | Purine Analogues |
10 | Dacarbazine injection 500 mg | Purine Analogues |
11 | Dactanomycin injection 0.5 mg | Antitumor antibiotics |
12 | Daunorubicin injection 20 mg | Anthracyclines |
13 | Doxorubicin injection 10 mg | Anthracyclines |
14 | Doxorubicin injection 50 mg | Anthracyclines |
15 | Epirubicin injection 10 mg | Anthracyclines |
16 | Epirubicin injection 50 mg | Anthracyclines |
17 | Fludarabine phosphate injection 50 mg | Purine analogs |
18 | Fosaprepitant injection 150 mg | Antiemetics |
19 | Gemcitabine injection 1000 mg | Antimetabolites |
20 | Gemcitabine injection 1400 mg | Antimetabolites |
21 | Gemcitabine injection 200 mg | Antimetabolites |
22 | L-asparagenase injection 10000 IU | Antineoplastic |
23 | L-asparagenase injection 5000 IU | Antineoplastic |
24 | Mitomycin injection 10 mg | Antineoplastic |
25 | Oxaliplatin injection 100 mg | paltinum base chemotherapeutic |
26 | Oxaliplatin injection 50 mg | paltinum base chemotherapeutic |
27 | Paclitacxel Albumin bound 100 mg | Antimicrotubule agents |
28 | Zoldrenic acid 4 mg | Antiresorptive |
LIQUID INJECTION | ||
SR.NO. | PRODUCT NAME | THERAPEUTICAL CLASS |
1 | Carbazitaxel injection 60 m+B102:B128g | Microtubule agents |
2 | Carboplatin injection 150 mg | Platinum caoyning compound |
3 | Carboplatin injection 450 mg | Platinum caoyning compound |
4 | Cisplatin injection 100 mg | Alklyzing agent |
5 | Cisplatin injection 50 mg | Alklyzing agent |
6 | Cytarabine injection 100 mg | Antimetabolite & Antineoplastic agent |
7 | Cytarabine injection 1000 mg | Antimetabolite & Antineoplastic agent |
8 | Cytarabine injection 500 mg | Antimetabolite & Antineoplastic agent |
9 | Docetaxel injection (Ready to use) Romm temperature | Taxanes |
10 | Docetaxel injection with solvent (2-8 Degree) | Taxanes |
11 | Doxorubicin injection 50 mg | Anthracyclines |
12 | PEG-Asparagenase 3750 IU | Antineoplastic agent |
13 | Epirubicin injection 10 mg | Anthracyclines |
14 | Epirubicin injection 50 mg | Anthracyclines |
15 | Etoposide injection 100 mg | Topoisomer inhibitords |
16 | Fluorourocil injection 1000 mg | Antimetabolite |
17 | Fluorourocil injection 250 mg | Antimetabolite |
18 | Fluorourocil injection 500 mg | Antimetabolite |
19 | Gemcitabine injection 1000 mg | Antimetabolites |
20 | Gemcitabine injection 1400 mg | Antimetabolites |
21 | Gemcitabine injection 200 mg | Antimetabolites |
22 | Gemcitabine injection 2000 mg | Antimetabolites |
23 | Irinotecan injection 40 mg | DNA topoisomerase I Inhibitors |
24 | Leucovorin calcium injection 100 mg | Folic acid analogs |
25 | Leucovorin calcium injection 300 mg | Folic acid analogs |
26 | Leucovorin calcium injection 50 mg | Folic acid analogs |
27 | Methotrexate injection 50 mg | Antimetabolites |
28 | Methotrexate injection 500 mg | Antimetabolites |
29 | Oxaliplatin injection 100 mg | Platinum base chemotherapeutic |
30 | Oxaliplatin injection 50 mg | Platinum base chemotherapeutic |
31 | Paclitaxel injection 100 mg | Antimicrotubule agents |
32 | Paclitaxel injection 260 mg | Antimicrotubule agents |
33 | Paclitaxel injection 30 mg | Antimicrotubule agents |
34 | Paclitaxel injection 300 mg | Antimicrotubule agents |
35 | Vinblastin injection 10 mg | Vinca alkaloids |
36 | Vincristine injection 1 mg | Vinca alkaloids |
37 | Vinorelbine injection 50 mg | Vinca alkaloids |